American Century Companies’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
QF
FCM
American Century Companies's ROIV Position: Q2 2026 in Review
American Century Companies increased its Roivant Sciences (ROIV) stake by 11% in Q2 2026, buying an estimated $389K and bringing the position to 127,794 shares worth $4.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1922.
American Century Companies first reported a position in ROIV in Q3 2022 and has held it in 16 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.
- American Century Companies held 127,794 shares of Roivant Sciences worth $4.52M as of Q2 2026.
- American Century Companies bought 13,167 Roivant Sciences shares in Q2 2026, an estimated $389K.
- Roivant Sciences made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #1922 holding.
- American Century Companies first reported a position in Roivant Sciences in Q3 2022 and has held it in 16 quarters since.
- 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.